Furthermore, there are also more specific and potent mitochondrial inhibitors currently being deployed in the clinic55, including in pancreatic cancer (NCT03291938), and these could similarly benefit from combination with asparaginase. The gene discussed is ASPG; the disease is pancreatic neoplasm.